Novolog (Pharm-Up 1966) Ltd
NVLG.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$43.17B
Close$
Share Statistics
| Market cap | $43.17 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $3.91 (5.04%) |
| Earnings per Share | $0.01 |
| Beta | 0.14 |
| Outstanding Shares | 510,875,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -597.69 |
|---|---|
| PEG | 676.88 |
| Price to Sales | 28.17 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Novolog (Pharm-Up 1966) Ltd
916 employees
CEO: Aviad Bossi Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceutica...